| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.16 | 7e-05 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.12 | 8e-05 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0001 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.15 | 0.0001 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0002 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0003 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0004 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0004 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0004 |